Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai, P.R. China.
Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai, P.R. China.
World Neurosurg. 2020 Jan;133:e187-e196. doi: 10.1016/j.wneu.2019.08.189. Epub 2019 Sep 4.
To investigate outcomes and prognostic factors of ruptured middle cerebral artery (MCA) aneurysms, treated via endovascular approach, with improving treatment materials and techniques.
A total of 185 consecutive patients, admitted with acutely ruptured MCA aneurysms and treated by endovascular methods between 2006 and 2016, were retrospectively reviewed. Their baseline characteristics, procedure-related complications, and angiographic and clinical outcomes were collected. Univariate analysis and logistic regression analysis were completed to identify any association between procedure-related complications or clinical outcomes and potential risk factors.
Procedure-related complications occurred in 28 patients (15.1%), including aneurysm rebleeding in 7 (3.8%), hematoma expansion in 10 (5.4%), and ischemia in 13 (7.0%) (concurrent hemorrhage and ischemia in 2 patients), which resulted in morbidity/mortality of 7% and 1.4%. Final evaluations indicated that 153 patients (82.7%, 153/185) had a good outcome (modified Rankin Scale score 0-2). Among 120 (69.4%) who underwent angiographic follow-up, 89 (74.2%) were completely occluded and 20/120 (16.7%) were recanalized. Multivariate analysis of clinical outcome indicated that a high preoperative Hunt and Hess grade (IV-V), intrasylvian/intracerebral hematoma, and early period treatment (2006-2013) were associated with unfavorable outcomes.
Endovascular treatment for patients with ruptured middle cerebral artery aneurysms may offer favorable clinical and angiographic outcomes. With the evolution of treatment materials and updated techniques, treatment complications have become less common than previously reported in literature, and clinical outcomes have been improved in recent years.
探讨采用血管内方法治疗破裂的大脑中动脉(MCA)动脉瘤的结果和预后因素,随着治疗材料和技术的改进。
回顾性分析了 2006 年至 2016 年间因急性破裂 MCA 动脉瘤接受血管内治疗的 185 例连续患者。收集了他们的基线特征、与程序相关的并发症以及血管造影和临床结果。完成了单变量分析和逻辑回归分析,以确定与程序相关的并发症或临床结果与潜在风险因素之间的任何关联。
28 例(15.1%)患者发生与程序相关的并发症,包括 7 例(3.8%)动脉瘤再出血、10 例(5.4%)血肿扩大和 13 例(7.0%)缺血(2 例同时出血和缺血),导致发病率/死亡率为 7%和 1.4%。最终评估表明,153 例(82.7%,153/185)的预后良好(改良 Rankin 量表评分 0-2)。在 120 例(69.4%)接受血管造影随访的患者中,89 例(74.2%)完全闭塞,20/120 例(16.7%)再通。临床结果的多变量分析表明,术前 Hunt 和 Hess 分级较高(IV-V)、大脑镰/脑内血肿以及早期治疗(2006-2013 年)与不良结局相关。
血管内治疗破裂的大脑中动脉动脉瘤可能提供良好的临床和血管造影结果。随着治疗材料的发展和更新技术的出现,治疗并发症比文献中以前报道的要少见,近年来临床结果得到了改善。